Published in AJNR Am J Neuroradiol on January 14, 2010
Comparing predictors of conversion and decline in mild cognitive impairment. Neurology (2010) 5.69
Multimodal classification of Alzheimer's disease and mild cognitive impairment. Neuroimage (2011) 5.24
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement (2011) 4.25
The Alzheimer's disease neuroimaging initiative: progress report and future plans. Alzheimers Dement (2010) 3.85
Predictive markers for AD in a multi-modality framework: an analysis of MCI progression in the ADNI population. Neuroimage (2010) 3.58
Multi-modal multi-task learning for joint prediction of multiple regression and classification variables in Alzheimer's disease. Neuroimage (2011) 3.47
Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative. Alzheimers Dement (2010) 2.88
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement (2013) 2.32
Boosting power for clinical trials using classifiers based on multiple biomarkers. Neurobiol Aging (2010) 2.13
Multi-method analysis of MRI images in early diagnostics of Alzheimer's disease. PLoS One (2011) 1.79
Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers. Radiology (2012) 1.74
Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors. PLoS One (2011) 1.66
Diagnostic neuroimaging across diseases. Neuroimage (2011) 1.66
Can MRI screen for CSF biomarkers in neurodegenerative disease? Neurology (2012) 1.52
Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia. Trends Neurosci (2011) 1.51
Sparse reduced-rank regression detects genetic associations with voxel-wise longitudinal phenotypes in Alzheimer's disease. Neuroimage (2011) 1.41
Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition. Brain (2011) 1.41
Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease. Acta Neuropathol (2010) 1.38
A computational neurodegenerative disease progression score: method and results with the Alzheimer's disease Neuroimaging Initiative cohort. Neuroimage (2012) 1.31
Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease. Alzheimers Dement (2014) 1.28
Inter-modality relationship constrained multi-modality multi-task feature selection for Alzheimer's Disease and mild cognitive impairment identification. Neuroimage (2013) 1.27
The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease. J Neurosci (2011) 1.26
Accurate multimodal probabilistic prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment. Neuroimage Clin (2013) 1.25
Relative capability of MR imaging and FDG PET to depict changes associated with prodromal and early Alzheimer disease. Radiology (2010) 1.22
Latent feature representation with stacked auto-encoder for AD/MCI diagnosis. Brain Struct Funct (2013) 1.16
Hierarchical feature representation and multimodal fusion with deep learning for AD/MCI diagnosis. Neuroimage (2014) 1.13
Estrogen: a master regulator of bioenergetic systems in the brain and body. Front Neuroendocrinol (2013) 1.10
Ventricular maps in 804 ADNI subjects: correlations with CSF biomarkers and clinical decline. Neurobiol Aging (2010) 1.10
Whole brain and regional hyperintense white matter volume and blood pressure: overlap of genetic loci produced by bivariate, whole-genome linkage analyses. Stroke (2010) 1.09
Morphological and pathological evolution of the brain microcirculation in aging and Alzheimer's disease. PLoS One (2012) 1.09
Arterial spin labeling MRI: an emerging biomarker for Alzheimer's disease and other neurodegenerative conditions. Curr Opin Neurol (2012) 1.08
Modeling Disease Progression via Fused Sparse Group Lasso. KDD (2012) 1.07
White matter imaging contributes to the multimodal diagnosis of frontotemporal lobar degeneration. Neurology (2012) 1.05
Clinical utility and analytical challenges in measurement of cerebrospinal fluid amyloid-β(1-42) and τ proteins as Alzheimer disease biomarkers. Clin Chem (2013) 1.04
Bi-level multi-source learning for heterogeneous block-wise missing data. Neuroimage (2013) 1.02
MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy study. BMJ Open (2013) 0.99
Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers. Neuroimage Clin (2013) 0.99
Preclinical AD Workgroup staging: pathological correlates and potential challenges. Neurobiol Aging (2011) 0.99
BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer's Disease. PLoS One (2013) 0.98
Alliance for aging research AD biomarkers work group: structural MRI. Neurobiol Aging (2011) 0.98
Neuropathological associates of multiple cognitive functions in two community-based cohorts of older adults. J Int Neuropsychol Soc (2011) 0.97
Relationship between baseline brain metabolism measured using [¹⁸F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease. Brain Imaging Behav (2012) 0.96
Independent component analysis-based classification of Alzheimer's disease MRI data. J Alzheimers Dis (2011) 0.96
Manifold regularized multitask feature learning for multimodality disease classification. Hum Brain Mapp (2014) 0.93
Diagnosis and biomarkers of predementia in Alzheimer's disease. BMC Med (2010) 0.93
Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer's disease. Brain Imaging Behav (2012) 0.92
Brain functional network in Alzheimer's disease: diagnostic markers for diagnosis and monitoring. Int J Alzheimers Dis (2011) 0.91
Application of the National Institute on Aging-Alzheimer's Association AD criteria to ADNI. Neurology (2013) 0.91
The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans. Alzheimers Dement (2015) 0.90
Aberrant hippocampal subregion networks associated with the classifications of aMCI subjects: a longitudinal resting-state study. PLoS One (2011) 0.89
Role of structural MRI in Alzheimer's disease. Alzheimers Res Ther (2010) 0.88
Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease. Neurobiol Aging (2013) 0.86
Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series. Alzheimers Dement (2013) 0.86
Magnetization-prepared rapid acquisition with gradient echo magnetic resonance imaging signal and texture features for the prediction of mild cognitive impairment to Alzheimer's disease progression. J Med Imaging (Bellingham) (2014) 0.86
Meta-Review of CSF Core Biomarkers in Alzheimer's Disease: The State-of-the-Art after the New Revised Diagnostic Criteria. Front Aging Neurosci (2014) 0.86
Structural covariance of the default network in healthy and pathological aging. J Neurosci (2013) 0.86
A focus on structural brain imaging in the Alzheimer's disease neuroimaging initiative. Biol Psychiatry (2013) 0.86
A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysis. Biomed Res Int (2014) 0.85
Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting. Eur J Nucl Med Mol Imaging (2015) 0.85
Prognostic classification of mild cognitive impairment and Alzheimer's disease: MRI independent component analysis. Psychiatry Res (2014) 0.84
Subclass-based multi-task learning for Alzheimer's disease diagnosis. Front Aging Neurosci (2014) 0.84
cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases. Int J Alzheimers Dis (2010) 0.84
ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease. Neuroimage Clin (2014) 0.83
Quantitative markers for neuropsychiatric disease: give it a rest. Radiology (2011) 0.83
Semi-supervised multimodal relevance vector regression improves cognitive performance estimation from imaging and biological biomarkers. Neuroinformatics (2013) 0.82
Entorhinal cortex volume is associated with episodic memory related brain activation in normal aging and amnesic mild cognitive impairment. Brain Imaging Behav (2011) 0.81
Modular reorganization of brain resting state networks and its independent validation in Alzheimer's disease patients. Front Hum Neurosci (2013) 0.81
Tau pathology: predictive diagnostics, targeted preventive and personalized medicine and application of advanced research in medical practice. EPMA J (2010) 0.80
Spatial Navigation in Preclinical Alzheimer's Disease. J Alzheimers Dis (2016) 0.80
Deep sparse multi-task learning for feature selection in Alzheimer's disease diagnosis. Brain Struct Funct (2015) 0.80
A Comparison of Magnetic Resonance Imaging and Neuropsychological Examination in the Diagnostic Distinction of Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia. Front Aging Neurosci (2016) 0.80
Residual vectors for Alzheimer disease diagnosis and prognostication. Brain Behav (2011) 0.79
Significance of normalization on anatomical MRI measures in predicting Alzheimer's disease. ScientificWorldJournal (2014) 0.79
FDG-PET for early assessment of Alzheimer's disease: isn't the evidence base large enough? Eur J Nucl Med Mol Imaging (2010) 0.79
Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2. Alzheimers Dement (2015) 0.79
Latent information in fluency lists predicts functional decline in persons at risk for Alzheimer disease. Cortex (2014) 0.78
The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease. PLoS One (2016) 0.77
Multimodal Discrimination of Alzheimer's Disease Based on Regional Cortical Atrophy and Hypometabolism. PLoS One (2015) 0.77
Transcriptomics of cortical gray matter thickness decline during normal aging. Neuroimage (2013) 0.77
Neuroimaging and genetic risk for Alzheimer's disease and addiction-related degenerative brain disorders. Brain Imaging Behav (2014) 0.76
Inclusion of Neuropsychological Scores in Atrophy Models Improves Diagnostic Classification of Alzheimer's Disease and Mild Cognitive Impairment. Comput Intell Neurosci (2015) 0.76
Potential Clinical Value of Multiparametric PET in the Prediction of Alzheimer's Disease Progression. PLoS One (2016) 0.75
A review of neuroimaging biomarkers of Alzheimer's disease. Neurol Asia (2013) 0.75
Recent Progress in Alzheimer's Disease Research, Part 3: Diagnosis and Treatment. J Alzheimers Dis (2017) 0.75
Improved Diagnostic Multimodal Biomarkers for Alzheimer's Disease and Mild Cognitive Impairment. Biomed Res Int (2015) 0.75
Multi-task diagnosis for autism spectrum disorders using multi-modality features: A multi-center study. Hum Brain Mapp (2017) 0.75
Transmodal Learning of Functional Networks for Alzheimer's Disease Prediction. IEEE J Sel Top Signal Process (2016) 0.75
Practice Effects on Story Memory and List Learning Tests in the Neuropsychological Assessment of Older Adults. PLoS One (2016) 0.75
Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database. Alzheimers Res Ther (2017) 0.75
Joint Coupled-Feature Representation and Coupled Boosting for AD Diagnosis. Proc IEEE Comput Soc Conf Comput Vis Pattern Recognit (2015) 0.75
Cross contrast multi-channel image registration using image synthesis for MR brain images. Med Image Anal (2016) 0.75
Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia. Alzheimers Res Ther (2017) 0.75
Interactive versus additive relationships between regional cortical thinning and amyloid burden in predicting clinical decline in mild AD and MCI individuals. Neuroimage Clin (2017) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology (1993) 47.72
Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage (1999) 40.38
Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron (2002) 33.99
A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology (1983) 30.77
Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage (1999) 29.82
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage (2006) 25.52
A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging (1998) 23.54
Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A (2000) 19.87
Automatically parcellating the human cerebral cortex. Cereb Cortex (2004) 18.32
High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum Brain Mapp (1999) 16.32
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol (2009) 14.42
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol (2006) 9.99
Improved Localizadon of Cortical Activity by Combining EEG and MEG with MRI Cortical Surface Reconstruction: A Linear Approach. J Cogn Neurosci (1993) 8.64
Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. Neuroimage (2005) 8.50
Thinning of the cerebral cortex in aging. Cereb Cortex (2004) 8.31
Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology (2002) 5.40
Regionally localized thinning of the cerebral cortex in schizophrenia. Arch Gen Psychiatry (2003) 4.84
MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers. Brain (2009) 4.51
Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology (2006) 4.06
Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics. Nat Rev Drug Discov (2007) 4.03
Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI. Neuroimage (2008) 3.74
Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging (2001) 3.25
Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? Mol Chem Neuropathol (1995) 3.23
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment. Neurobiol Aging (2005) 3.00
Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J Nucl Med (2008) 2.92
Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. Radiology (2009) 2.90
Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Neuroimage (2009) 2.80
Multi-modal imaging predicts memory performance in normal aging and cognitive decline. Neurobiol Aging (2008) 2.31
Structural MRI biomarkers for preclinical and mild Alzheimer's disease. Hum Brain Mapp (2009) 2.24
Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. J Nucl Med (2006) 2.17
MRI-Based topographic parcellation of human cerebral white matter and nuclei II. Rationale and applications with systematics of cerebral connectivity. Neuroimage (1999) 2.15
Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease. J Neurosci (2008) 2.15
Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease. Ann N Y Acad Sci (2007) 2.11
Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition. Neuroimage (2009) 2.03
Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis. J Comput Assist Tomogr (1995) 1.88
Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: a longitudinal study. Neurobiol Aging (2008) 1.67
Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls. Neuroimage (2009) 1.63
Brain structure and cognition in a community sample of elderly Latinos. Neurology (2002) 1.62
Amnestic mild cognitive impairment: structural MR imaging findings predictive of conversion to Alzheimer disease. AJNR Am J Neuroradiol (2008) 1.50
Early detection of Alzheimer's disease using neuroimaging. Exp Gerontol (2006) 1.41
Morphometric changes in the episodic memory network and tau pathologic features correlate with memory performance in patients with mild cognitive impairment. AJNR Am J Neuroradiol (2008) 1.24
Multimodal imaging in mild cognitive impairment: Metabolism, morphometry and diffusion of the temporal-parietal memory network. Neuroimage (2008) 1.19
Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer's disease. J Cereb Blood Flow Metab (1983) 1.13
Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease. Neurobiol Aging (2007) 1.12
Brain function and cognition in a community sample of elderly Latinos. Neurology (2002) 1.05
PET network abnormalities and cognitive decline in patients with mild cognitive impairment. Neuropsychopharmacology (2006) 0.94
Beta-amyloid (Abeta) protein in cerebrospinal fluid as a biomarker for Alzheimer's disease. Peptides (2002) 0.94
Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage (1999) 29.82
Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A (2000) 19.87
High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum Brain Mapp (1999) 16.32
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol (2009) 14.42
Borders of multiple visual areas in humans revealed by functional magnetic resonance imaging. Science (1995) 12.98
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology (2010) 12.32
A hybrid approach to the skull stripping problem in MRI. Neuroimage (2004) 9.59
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Trans Med Imaging (2001) 8.14
Building memories: remembering and forgetting of verbal experiences as predicted by brain activity. Science (1998) 7.58
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain (2009) 7.20
Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain (2008) 6.29
Comparing predictors of conversion and decline in mild cognitive impairment. Neurology (2010) 5.69
Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. Arch Neurol (2010) 5.53
Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology (2002) 5.40
Top-down facilitation of visual recognition. Proc Natl Acad Sci U S A (2006) 5.38
Multimodal classification of Alzheimer's disease and mild cognitive impairment. Neuroimage (2011) 5.24
Protective variant for hippocampal atrophy identified by whole exome sequencing. Ann Neurol (2015) 5.10
Two-dimensional real-time ultrasonic imaging of the heart and great vessels. Technique, image orientation, structure identification, and validation. Mayo Clin Proc (1978) 4.92
An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood (1996) 4.65
MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers. Brain (2009) 4.51
Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease. Brain (2010) 4.39
Age-related alterations in white matter microstructure measured by diffusion tensor imaging. Neurobiol Aging (2004) 4.38
Automatic classification of patients with Alzheimer's disease from structural MRI: a comparison of ten methods using the ADNI database. Neuroimage (2010) 4.28
Relationships between biomarkers in aging and dementia. Neurology (2009) 4.16
Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline. Neuroimage (2007) 4.07
Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging (2009) 3.97
The Alzheimer's disease neuroimaging initiative: progress report and future plans. Alzheimers Dement (2010) 3.85
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change. Neurology (2009) 3.72
Effects of age on tissues and regions of the cerebrum and cerebellum. Neurobiol Aging (2001) 3.68
Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients. J Am Coll Cardiol (1985) 3.66
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Neurology (2012) 3.58
Multi-modal multi-task learning for joint prediction of multiple regression and classification variables in Alzheimer's disease. Neuroimage (2011) 3.47
Retinotopy and color sensitivity in human visual cortical area V8. Nat Neurosci (1998) 3.41
Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects. Neuroimage (2008) 3.40
Functional analysis of V3A and related areas in human visual cortex. J Neurosci (1997) 3.33
The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimers Dement (2010) 3.30
Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort. Neuroimage (2010) 3.27
The retinotopy of visual spatial attention. Neuron (1998) 3.18
Fast and robust multi-atlas segmentation of brain magnetic resonance images. Neuroimage (2009) 3.13
Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans. Alzheimers Dement (2010) 3.11
Blood-based protein biomarkers for diagnosis of Alzheimer disease. Arch Neurol (2012) 3.03
Functional MRI reveals spatially specific attentional modulation in human primary visual cortex. Proc Natl Acad Sci U S A (1999) 3.02
Stochastic designs in event-related fMRI. Neuroimage (1999) 2.97
Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. Radiology (2009) 2.90
Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative. Alzheimers Dement (2010) 2.88
Event-related activation in the human amygdala associates with later memory for individual emotional experience. J Neurosci (2000) 2.85
Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease. PLoS One (2009) 2.85
Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Ann Neurol (2012) 2.84
Evidence for ordering of Alzheimer disease biomarkers. Arch Neurol (2011) 2.83
MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations. Neurology (2009) 2.83
Randomized event-related experimental designs allow for extremely rapid presentation rates using functional MRI. Neuroreport (1998) 2.80
Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Neuroimage (2009) 2.80
Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans. Alzheimers Dement (2010) 2.79
Cortical mechanisms specific to explicit visual object recognition. Neuron (2001) 2.77
Voxelwise genome-wide association study (vGWAS). Neuroimage (2010) 2.69
Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects. Alzheimers Dement (2010) 2.68
Estimation and detection of event-related fMRI signals with temporally correlated noise: a statistically efficient and unbiased approach. Hum Brain Mapp (2000) 2.67
Surgical treatment of vascular rings: the Mayo Clinic experience. Mayo Clin Proc (1993) 2.63
Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease. Brain (2009) 2.61
Functional-anatomic correlates of object priming in humans revealed by rapid presentation event-related fMRI. Neuron (1998) 2.61
Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve. Brain (2009) 2.51
Longitudinal change of biomarkers in cognitive decline. Arch Neurol (2011) 2.51
A progressive shuttle run test to estimate maximal oxygen uptake. Br J Sports Med (1988) 2.50
Bias in tensor based morphometry Stat-ROI measures may result in unrealistic power estimates. Neuroimage (2011) 2.50
Spatially augmented LPboosting for AD classification with evaluations on the ADNI dataset. Neuroimage (2009) 2.47
Brain dysmorphology in individuals with severe prenatal alcohol exposure. Dev Med Child Neurol (2001) 2.44
Automatic quality assessment in structural brain magnetic resonance imaging. Magn Reson Med (2009) 2.43
Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort. Chest (1995) 2.43
Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI. Acta Neuropathol (2011) 2.41
3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry. Neuroimage (2008) 2.40
Subregional neuroanatomical change as a biomarker for Alzheimer's disease. Proc Natl Acad Sci U S A (2009) 2.37
Functional analysis of primary visual cortex (V1) in humans. Proc Natl Acad Sci U S A (1998) 2.37
Visual motion aftereffect in human cortical area MT revealed by functional magnetic resonance imaging. Nature (1995) 2.33
Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease. Neuroimage (2010) 2.32
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement (2013) 2.32
Multi-modal imaging predicts memory performance in normal aging and cognitive decline. Neurobiol Aging (2008) 2.31
Validation of a fully automated 3D hippocampal segmentation method using subjects with Alzheimer's disease mild cognitive impairment, and elderly controls. Neuroimage (2008) 2.30
Cortical fMRI activation produced by attentive tracking of moving targets. J Neurophysiol (1998) 2.29
Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database. Brain (2008) 2.28
Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects. Neuroimage (2009) 2.28
Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Hum Brain Mapp (2009) 2.28
Discovering genetic associations with high-dimensional neuroimaging phenotypes: A sparse reduced-rank regression approach. Neuroimage (2010) 2.27
Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Neuroimage (2008) 2.25
Structural MRI biomarkers for preclinical and mild Alzheimer's disease. Hum Brain Mapp (2009) 2.24
Bias in estimation of hippocampal atrophy using deformation-based morphometry arises from asymmetric global normalization: an illustration in ADNI 3 T MRI data. Neuroimage (2009) 2.22
Serial MRI and CSF biomarkers in normal aging, MCI, and AD. Neurology (2010) 2.20
Age-related changes in prefrontal white matter measured by diffusion tensor imaging. Ann N Y Acad Sci (2005) 2.18
Regional rates of neocortical atrophy from normal aging to early Alzheimer disease. Neurology (2009) 2.18